Cases & Deals

  • Home
  • Practices
  • Cellnovo completes €17.5 million private placement of new shares

Share

Cellnovo completes €17.5 million private placement of new shares

July 2017

Client(s) Cellnovo Group

Jones Day advised Cellnovo, a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, listed on the regulated market of Euronext in Paris, and Oddo BHF in connection with the €17.5 million (US$19.9 million) private placement of Cellnovo new shares to European investors.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.